Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Carc. 1B - Chem. Unst. Gas A - Eye Dam. 1 - Flam. Gas 1A - Muta. 1B - Press. Gas Liquefied gas - Repr. 1B - Skin Corr. 1B - STOT RE 1 - STOT SE 3
Target Organs
Central nervous system, Nervous system, Respiratory system
Storage Class Code
2A - Gases
WGK
WGK 3
Flash Point(F)
-4.0 °F - closed cup
Flash Point(C)
-20.0 °C - closed cup
Regulatory Listings
Regulatory Listings are mainly provided for chemical products. Only limited information can be provided here for non-chemical products. No entry means none of the components are listed. It is the user’s obligation to ensure the safe and legal use of the product.
The results of efforts to identify and quantify macromolecular adducts of ethylene oxide (ETO), to determine the source and significance of background levels of these adducts, and to generate molecular dosimetry data on these adducts are reviewed. A time-course study
Journal of hazardous materials, 108(3), 147-159 (2004-05-04)
This paper discusses a methodology for the design of an optimum inspection and maintenance program. The methodology, called risk-based maintenance (RBM) is based on integrating a reliability approach and a risk assessment strategy to obtain an optimum maintenance schedule. First
Critical reviews in toxicology, 29(3), 263-282 (1999-06-24)
Cytogenetic assays are an integral component of the battery of short-term assays that are used for the hazard identification component of a cancer risk assessment. The protocol for the conduct of such assays for maximal sensitivity for detecting clastogenicity has
Data for relationships between in vivo doses inferred from levels of hemoglobin (Hb) or DNA adducts and administered (by inhalation or injection) doses of ethylene oxide (EO) in mice, rats and humans are reviewed. At low absorbed doses or dose
Critical reviews in toxicology, 30(5), 595-608 (2000-10-31)
Long-term inhalation studies in rodents have presented unequivocal evidence of experimental carcinogenicity of ethylene oxide, based on the formation of malignant tumors at multiple sites. However, despite a considerable body of epidemiological data only limited evidence has been obtained of
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
